cas2363-sup-0001-FigureS1-S7.pdfapplication/PDF231KFig. S1. IC50 values of erlotinib and gefitinib in PC-9 and PC-9/ER3, 4 and 5 cells determined by MTT assay. Fig. S2. MET gene copy number relative to GAPDH in PC-9 and PC-9/ER1, 2, 3, 4 and 5 cells. Fig. S3. Protein expression in PC-9 and PC-9/ER3, 4 and 5 cells treated with or without erlotinib for 6 h. Fig. S4. Target protein expression in PC-9 and PC-9/ER3 cells treated with each indicated concentrations of LY294002 or Stattic. Fig. S5. Growth inhibition ratio after treatment with erlotinib plus JSI-124 of PC-9/ER5 cells. Fig. S6. The combination of erlotinib with inhibition of JAK2 using siRNA in PC-9/ER3 cells suppressed pAkt in PC-9/ER3 cells. Fig. S7. Inhibition of JAK2 suppresses c-MYC expression.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.